Literature DB >> 15221861

Prospects and implications of using chromatin insulators in gene therapy and transgenesis.

Félix Recillas-Targa1, Viviana Valadez-Graham, Catherine M Farrell.   

Abstract

Gene therapy has emerged from the idea of inserting a wild-type copy of a gene in order to restore the proper expression and function of a damaged gene. Initial efforts have focused on finding the proper vector and delivery method to introduce a corrected gene to the affected tissue or cell type. Even though these first attempts are clearly promising, several problems remain unsolved. A major problem is the influence of chromatin structure on transgene expression. To overcome chromatin-dependent repressive transgenic states, researchers have begun to use chromatin regulatory elements to drive transgene expression. Insulators or chromatin boundaries are able to protect a transgene against chromatin position effects at their genomic integration sites, and they are able to maintain transgene expression for long periods of time. Therefore, these elements may be very useful tools in gene therapy applications for ensuring high-level and stable expression of transgenes. Copyright 2004 Wiley Periodicals, Inc.

Mesh:

Substances:

Year:  2004        PMID: 15221861     DOI: 10.1002/bies.20059

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  25 in total

Review 1.  A realistic chance for gene therapy in the near future.

Authors:  Stefan Worgall
Journal:  Pediatr Nephrol       Date:  2004-11-10       Impact factor: 3.714

2.  Identification, genome mapping, and CTCF binding of potential insulators within the FXYD5-COX7A1 locus of human chromosome 19q13.12.

Authors:  Sergey B Akopov; Vera M Ruda; Vera V Batrak; Anna S Vetchinova; Igor P Chernov; Lev G Nikolaev; Jürgen Bode; Eugene D Sverdlov
Journal:  Mamm Genome       Date:  2006-10-03       Impact factor: 2.957

3.  Mutation of a barrier insulator in the human ankyrin-1 gene is associated with hereditary spherocytosis.

Authors:  Patrick G Gallagher; Laurie A Steiner; Robert I Liem; Ashley N Owen; Amanda P Cline; Nancy E Seidel; Lisa J Garrett; David M Bodine
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

Review 4.  Multiple strategies for gene transfer, expression, knockdown, and chromatin influence in mammalian cell lines and transgenic animals.

Authors:  Félix Recillas-Targa
Journal:  Mol Biotechnol       Date:  2006-11       Impact factor: 2.695

5.  An insulator with barrier-element activity promotes alpha-spectrin gene expression in erythroid cells.

Authors:  Patrick G Gallagher; Douglas G Nilson; Laurie A Steiner; Yelena D Maksimova; Jolinta Y Lin; David M Bodine
Journal:  Blood       Date:  2008-11-13       Impact factor: 22.113

6.  Investigation of the properties of non-gypsy suppressor of hairy-wing-binding sites.

Authors:  Emily J Kuhn-Parnell; Cecilia Helou; David J Marion; Brian L Gilmore; Timothy J Parnell; Marc S Wold; Pamela K Geyer
Journal:  Genetics       Date:  2008-06-18       Impact factor: 4.562

Review 7.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

8.  Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.

Authors:  Yoshitaka Miyagawa; Pietro Marino; Gianluca Verlengia; Hiroaki Uchida; William F Goins; Shinichiro Yokota; David A Geller; Osamu Yoshida; Joseph Mester; Justus B Cohen; Joseph C Glorioso
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

9.  Protection against telomeric position effects by the chicken cHS4 beta-globin insulator.

Authors:  Héctor Rincón-Arano; Mayra Furlan-Magaril; Félix Recillas-Targa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

Review 10.  Lentiviral vectors for immune cells targeting.

Authors:  Steven Froelich; April Tai; Pin Wang
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.